Global Genetic Testing Market Outlook (2015-2022)

June 2015 | 90 pages | ID: GF286F53336EN
Stratistics Market Research Consulting

Abstracts

The Global Genetic Testing Market accounted for $3.2 billion in 2014 and is expected to grow at a CAGR of 9.26% to reach $6.5 billion by 2022. The factors contributing to the market growth include aging population, growing awareness, availability of direct to consumer tests and increasing incidence of genetic disorder. However factors such as high cost for testing and reimbursement issues are inhibiting the growth of the market. Genetic testing for cancer is likely to be the fastest growing segment during the forecast period. Increasing incidence of genetic diseases is providing more opportunities for genetic testing along with the rise in personalized medicine. The federal agencies who play a significant role in regulating genetic tests are Food and Drug Administration (FDA), Federal Trade Commission (FTC) and Center for Medicare and Medicaid services (CMS).

Global Genetic Testing Market is segmented on the basis of application and geography. By Application, the market is categorized into Cancer Genetic Testing Market, Prenatal Genetic Testing Market, Pharmacogenomics Genetic Testing Market and Predisposition Cancer Genetic Testing Market. By geography, market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America leads the Genetic Testing Market followed by Europe.

Some of the key players in Genetic Testing Market include Abbott Laboratories, Biocartis SA, Applied Biosystems Inc., Celera Group, AutoGenomics Inc., Roche Diagnostics Limited, IntegraGen S.A, Transgenomic, Inc., Molecular Inc. and Luminex Corporation.

WHAT OUR REPORT OFFERS:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL GENETIC TESTING MARKET, BY APPLICATIONS

5.1 Cancer Genetic Testing Market
5.2 Prenatal Genetic Testing Market
5.3 Pharmacogenomics Genetic Testing Market
5.4 Predisposition Cancer Genetic Testing Market

6 GLOBAL GENETIC TESTING MARKET, BY GEOGRAPHY

6.1 North America
  6.1.1 US
  6.1.2 Canada
6.2 Europe
  6.2.1 Germany
  6.2.2 France
  6.2.3 Italy
  6.2.4 UK
  6.2.5 Spain
6.3 Asia Pacific
  6.3.1 Japan
  6.3.2 China
  6.3.3 India
  6.3.4 Australia
  6.3.5 Newzealand
  6.3.6 Rest of Asia
6.4 Rest of the World
  6.4.1 Latin America
  6.4.2 Middle East
  6.4.3 Africa
  6.4.4 Others

7 KEY DEVELOPMENTS

7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies

8 COMPANY PROFILING

8.1 Abbott Laboratories
8.2 Biocartis SA
8.3 Applied Biosystems Inc.
8.4 Celera Group
8.5 AutoGenomics Inc.
8.6 Roche Diagnostics Limited
8.7 IntegraGen S.A
8.8 Transgenomic, Inc.
8.9 Molecular Inc.
8.10 Luminex Corporation

List Of Tables

LIST OF TABLES

1 Global Genetic Testing Market Outlook, By Applications (2012-2022) ($MN)
2 Global Genetic Testing Market Outlook, By Cancer Genetic Testing Market (2012-2022) ($MN)
3 Global Genetic Testing Market Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
4 Global Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
5 Global Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing Market (2012-2022) ($MN)
6 North America Genetic Testing Market Outlook, By Applications (2012-2022) ($MN)
7 North America Genetic Testing Market Outlook, By Cancer Genetic Testing Market (2012-2022) ($MN)
8 North America Genetic Testing Market Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
9 North America Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
10 North America Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing Market (2012-2022) ($MN)
11 Europe Genetic Testing Market Outlook, By Applications (2012-2022) ($MN)
12 Europe Genetic Testing Market Outlook, By Cancer Genetic Testing Market (2012-2022) ($MN)
13 Europe Genetic Testing Market Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
14 Europe Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
15 Europe Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing Market (2012-2022) ($MN)
16 Asia Pacific Genetic Testing Market Outlook, By Applications (2012-2022) ($MN)
17 Asia Pacific Genetic Testing Market Outlook, By Cancer Genetic Testing Market (2012-2022) ($MN)
18 Asia Pacific Genetic Testing Market Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
19 Asia Pacific Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
20 Asia Pacific Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing Market (2012-2022) ($MN)
21 Rest Of The World Genetic Testing Market Outlook, By Applications (2012-2022) ($MN)
22 Rest Of The World Genetic Testing Market Outlook, By Cancer Genetic Testing Market (2012-2022) ($MN)
23 Rest Of The World Genetic Testing Market Outlook, By Prenatal Genetic Testing Market (2012-2022) ($MN)
24 Rest Of The World Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing Market (2012-2022) ($MN)
25 Rest Of The World Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing Market (2012-2022) ($MN)